In Vitro and in Vivo Assessement of the Antimalarial Activity of Sergeolide

Thierry Fandeur; Christian Moretti; Judith Polonsky

doi:10.1055/s-2007-969382

Planta Medica, Table of Contents

Planta Med 1985; 51(1): 20-23
DOI: 10.1055/s-2007-969382

Research Articles

In Vitro and in Vivo Assessement of the Antimalarial Activity of Sergeolide

Thierry Fandeur¹ , Christian Moretti² , Judith Polonsky³

¹Laboratoire d'immunologie parasitaire, Institut Pasteur de la Guyane Française, 97306, Cayenne Cedex, Guyane Française
²Unité de recherche des substances naturelles à intérêt biologique, Office de la Recherche Scientifique et Technique d'Outre Mer, BP 165, Cayenne, Guyane Française
³ICSN Gif sur Ivette, Lab. de Chemie.

Abstract

PDF Download

Abstract

The antimalarial activity of sergeolide (a quassinoid from Picrolemma pseudocoffea) was investigated both, in vitro on Plasmodium falciparum cultures and in vivo through a classical test of schizontocidal action against Plasmodium berghei in mice. Sergeolide showed a very strong antiplasmodial activity in vitro as well as in vivo. Low concentrations (0.006 µg/ml) were able to fully inhibit the in vitro growth of chloroquine-sensitive and resistant strains of P. falciparum. Small amounts (0.26 mg/kg/day) markedly reduced the virulence of experimentally induced P. berghei infection in mice. However, sergeolide, because of its high toxicity (LD 50: 1.8 mg/kg), does not seem, in its present form to be useful for malaria curative treatment.

PDF (354 kb)